Literature DB >> 29533680

Copy number variation in fetal alcohol spectrum disorder.

Mehdi Zarrei1, Geoffrey G Hicks2, James N Reynolds3,4, Bhooma Thiruvahindrapuram1, Worrawat Engchuan1, Molly Pind2, Sylvia Lamoureux1, John Wei1, Zhouzhi Wang1, Christian R Marshall1, Richard F Wintle1, Albert E Chudley5,6, Stephen W Scherer1,7.   

Abstract

Fetal alcohol spectrum disorder (FASD) is characterized by a combination of neurological, developmental, and congenital defects that may occur as a consequence of prenatal alcohol exposure. Earlier reports showed that large chromosomal anomalies may link to FASD. Here, we examined the prevalence and types of copy number variations (CNVs) in FASD cases previously diagnosed by a multidisciplinary FASD team in sites across Canada. We genotyped 95 children with FASD and 87 age-matched, typically developing controls on the Illumina Human Omni2.5 SNP (single nucleotide polymorphisms) array platform. We compared their CNVs with those of 10 851 population controls to identify rare CNVs (<0.1% frequency), which may include large unbalanced chromosomal abnormalities, that might be relevant to FASD. In 12/95 (13%) of the FASD cases, rare CNVs were found that impact potentially clinically relevant developmental genes, including the CACNA1H involved in epilepsy and autism, the 3q29 deletion disorder, and others. Our results show that a subset of children diagnosed with FASD have chromosomal deletions and duplications that may co-occur or explain the neurodevelopmental impairments in a diagnosed cohort of FASD individuals. Children suspected to have FASD with or without sentinel facial features of fetal alcohol syndrome and neurodevelopmental delays should potentially be evaluated by a clinical geneticist and possibly have genetic investigations as appropriate to exclude other etiologies.

Entities:  

Keywords:  CNV; FASD; TSAF; copy number variations; fetal alcohol spectrum disorder; troubles du spectre de l’alcoolisation fœtale; variabilité du nombre de copies

Mesh:

Year:  2018        PMID: 29533680     DOI: 10.1139/bcb-2017-0241

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  4 in total

Review 1.  Clinical presentation, diagnosis, and management of fetal alcohol spectrum disorder.

Authors:  Jeffrey R Wozniak; Edward P Riley; Michael E Charness
Journal:  Lancet Neurol       Date:  2019-05-31       Impact factor: 44.182

2.  Genome-Wide Transcriptome Landscape of Embryonic Brain-Derived Neural Stem Cells Exposed to Alcohol with Strain-Specific Cross-Examination in BL6 and CD1 Mice.

Authors:  Wayne Xu; Vichithra R B Liyanage; Aaron MacAulay; Romina D Levy; Kyle Curtis; Carl O Olson; Robby M Zachariah; Shayan Amiri; Marjorie Buist; Geoffrey G Hicks; James R Davie; Mojgan Rastegar
Journal:  Sci Rep       Date:  2019-01-18       Impact factor: 4.379

3.  Global DNA Methylation and Histone Posttranslational Modifications in Human and Nonhuman Primate Brain in Association with Prenatal Alcohol Exposure.

Authors:  Jessica S Jarmasz; Hannah Stirton; Duaa Basalah; James R Davie; Sterling K Clarren; Susan J Astley; Marc R Del Bigio
Journal:  Alcohol Clin Exp Res       Date:  2019-05-10       Impact factor: 3.455

4.  18q12.3-q21.1 microdeletion detected in the prenatally alcohol-exposed dizygotic twin with discordant fetal alcohol syndrome phenotype.

Authors:  Hanna Kahila; Heidi Marjonen; Pauliina Auvinen; Kristiina Avela; Raili Riikonen; Nina Kaminen-Ahola
Journal:  Mol Genet Genomic Med       Date:  2020-02-25       Impact factor: 2.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.